FARALLON CAPITAL MANAGEMENT LLC
Position in AGIO — Agios Pharmaceuticals, Inc.
CIK 909661
SAN FRANCISCO, CA
Position in AGIO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$192,289,720
+$51,847,994 QoQ
Shares Held
5,684,000
+10.2% QoQ
Ownership
9.56%
of shares outstanding
% of Portfolio
1.28%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AGIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FARALLON CAPITAL MANAGEMENT LLC holds $5,160,870,541 across 65 Biotechnology names. AGIO ranks #8 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
13,604,796 | $1,323,066,411 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
9,365,463 | $695,479,282 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
6,348,906 | $669,174,692 | |
| 4 | EXEL |
Exelixis, Inc.
|
13,111,010 | $562,331,218 | |
| 5 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
8,338,098 | $302,839,719 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
9,675,000 | $267,997,500 | |
| 7 | BEAM |
Beam Therapeutics Inc.
|
10,134,696 | $241,509,805 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
This page
|
5,684,000 | $192,289,720 |
All Filings in AGIO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $192,289,720 | 5,684,000 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $140,441,726 | 5,159,505 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $232,051,989 | 5,781,066 | Shares | Other | 2026-02-17 | |
| 2025-06-30 | $191,825,919 | 5,767,466 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $167,023,653 | 5,700,466 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $186,462,952 | 5,674,466 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $251,512,276 | 5,660,866 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $243,822,126 | 5,654,502 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $163,469,202 | 5,590,602 | Shares | Other | 2024-05-24 | |
| 2023-12-31 | $92,812,496 | 4,167,602 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $68,083,017 | 2,750,829 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $76,147,637 | 2,688,829 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $48,072,282 | 2,092,829 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $56,885,278 | 2,025,829 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $42,330,324 | 1,496,829 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $29,552,876 | 1,333,012 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $38,803,979 | 1,333,012 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $41,303,718 | 1,256,578 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $37,786,097 | 818,767 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $63,927,600 | 1,160,000 | Shares | Other | 2021-08-13 | |
| 2021-03-31 | $64,550,000 | 1,250,000 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $43,330,000 | 1,000,000 | Shares | Other | 2021-02-16 | |
| 2020-09-30 | $37,920,015 | 1,083,429 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $66,850,000 | 1,250,000 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $44,350,000 | 1,250,000 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||